InnateDB Protein
|
IDBP-69041.6
|
Last Modified
|
2014-10-13 [Report errors or provide feedback]
|
Gene Symbol
|
HRG
|
Protein Name
|
histidine-rich glycoprotein
|
Synonyms
|
HPRG; HRGP; THPH11;
|
Species
|
Homo sapiens
|
Ensembl Protein
|
ENSP00000232003
|
InnateDB Gene
|
IDBG-69039 (HRG)
|
Protein Structure
|
|
Function |
Plasma glycoprotein that binds a number of ligands such as heme, heparin, heparan sulfate, thrombospondin, plasminogen, and divalent metal ions. Binds heparin and heparin/glycosaminoglycans in a zinc-dependent manner. Binds heparan sulfate on the surface of liver, lung, kidney and heart endothelial cells. Binds to N-sulfated polysaccharide chains on the surface of liver endothelial cells. Inhibits rosette formation. Acts as an adapter protein and is implicated in regulating many processes such as immune complex and pathogen clearance, cell chemotaxis, cell adhesion, angiogenesis, coagulation and fibrinolysis. Mediates clearance of necrotic cells through enhancing the phagocytosis of necrotic cells in a heparan sulfate-dependent pathway. This process can be regulated by the presence of certain HRG ligands such as heparin and zinc ions. Binds to IgG subclasses of immunoglobins containing kappa and lambda light chains with different affinities regulating their clearance and inhibiting the formation of insoluble immune complexes. Tethers plasminogen to the cell surface. Binds T-cells and alters the cell morphology. Modulates angiogenesis by blocking the CD6-mediated antiangiongenic effect of thrombospondins, THBS1 and THBS2. Acts as a regulator of the vascular endothelial growth factor (VEGF) signaling pathway; inhibits endothelial cell motility by reducing VEGF-induced complex formation between PXN/paxillin and ILK/integrin-linked protein kinase and by promoting inhibition of VEGF-induced tyrosine phosphorylation of focal adhesion kinases and alpha-actinins in endothelial cells. Also plays a role in the regulation of tumor angiogenesis and tumor immune surveillance. Normalizes tumor vessels and promotes antitumor immunity by polarizing tumor-associated macrophages, leading to decreased tumor growth and metastasis. {ECO:0000269PubMed:11134179, ECO:0000269PubMed:12235005, ECO:0000269PubMed:14744774, ECO:0000269PubMed:15220341, ECO:0000269PubMed:15313924, ECO:0000269PubMed:16436387, ECO:0000269PubMed:16489009, ECO:0000269PubMed:19285951, ECO:0000269PubMed:19535045, ECO:0000269PubMed:19712047, ECO:0000269PubMed:19903770, ECO:0000269PubMed:20573803, ECO:0000269PubMed:21215706, ECO:0000269PubMed:21304106}.
|
Subcellular Localization |
Secreted {ECO:0000269PubMed:21215706}.
|
Disease Associations |
Thrombophilia due to histidine-rich glycoprotein deficiency (THPH11) [MIM:613116]: A hemostatic disorder characterized by a tendency to thrombosis. {ECO:0000269PubMed:11057869, ECO:0000269PubMed:9414276}. Note=The disease is caused by mutations affecting the gene represented in this entry.
|
Tissue Specificity |
Expressed in macrophages and in malignant cells. Expressed by the liver and secreted in plasma (at protein level). {ECO:0000269PubMed:14744774, ECO:0000269PubMed:19903770, ECO:0000269PubMed:21215706}.
|
Comments |
|
Number of Interactions
|
This gene and/or its encoded proteins are associated with 11 experimentally validated interaction(s) in this database.
Experimentally validated |
Total |
11
[view]
|
Protein-Protein |
11
[view]
|
Protein-DNA |
0
|
Protein-RNA |
0
|
DNA-DNA |
0
|
RNA-RNA |
0
|
DNA-RNA |
0
|
|
|
|
Molecular Function |
|
Biological Process |
|
Cellular Component |
|
PDB ID |
|
InterPro |
IPR000010
Proteinase inhibitor I25, cystatin
|
PFAM |
PF00031
|
PRINTS |
|
PIRSF |
|
SMART |
SM00043
|
TIGRFAMs |
|
Modification |
|
SwissProt |
P04196
|
PhosphoSite |
PhosphoSite-P04196
|
TrEMBL |
|
UniProt Splice Variant |
|
Entrez Gene |
3273
|
UniGene |
Hs.1498
|
RefSeq |
NP_000403
|
HUGO |
HGNC:5181
|
OMIM |
142640
|
CCDS |
CCDS3280
|
HPRD |
00812
|
IMGT |
|
EMBL |
AB005803
BC069574
BC150591
CH471052
M13149
Z17218
|
GenPept |
AAA52694
AAH69574
AAI50592
BAA21613
CAA78925
EAW78183
EAW78184
|
|
|